Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to ov...
This follows the company’s signing of a definitive agreement in October 2025 to ...
Under the agreement, Biocytogen’s fully human antibody discovery platform will b...
The IND includes results from completed toxicology, pharmacology, and manufactur...
Healthcare organizations often focus on designing welcoming lobbies and patient-...
The partnership aims to explore a new class of small molecules, called molecular...
Platform to support compliance, training and documentation for over 9,000 lear...
India's Foremost Pharma & Biotech Magazine ~ Patent Expiries Ahead: Is India Ph...
As pharma companies deal with price wars, increasing regulatory heat and a vola...
Acquisition to include orexin receptor portfolio for sleep and neurological co...
Harris County, Texas, Commissioners have authorized the use of eminent domain to...
The FDA approval of Ponlimsi is based on a comprehensive evidence package, inclu...
The partnership focuses on progressing Cellinfinity BIO’s programmes CIB-301 and...
Rusan Healthcare, the marketing and distribution arm of Rusan Pharma, an integr...
Granules India announced that its wholly owned subsidiary, Granules Life Scienc...
CORONA Remedies announced the acquisition of Wokadine from Dr. Reddy’s Laborato...
